ArticleCancers2026
3SGAN: Semi-Supervised and Multi-Task GAN for Stain Normalization and Nuclei Segmentation of Histopathological Images.
Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
BACKGROUND/
objectivesVariations in staining styles-arising from differences in tissue preparation, scanners, and laboratory protocols-severely compromise the robustness of automated cell segmentation algorithms in digital pathology. Moreover, manual nucleus annotation is extremely labor-intensive, leading to a scarcity of large-scale, fully annotated datasets for supervised nucleus segmentation. This study proposes a novel framework that simultaneously mitigates staining variability and achieves high-accuracy nucleus segmentation using only minimal annotations.
methodsWe present 3SGAN, a multi-task dual-branch generative adversarial network (GAN) that jointly performs stain normalization and nucleus segmentation in a semi-supervised manner. The framework adopts a teacher-student paradigm: a lightweight teacher model (AttCycle) equipped with attention gates generates reliable pseudo-labels, while a high-capacity student model (TransCycle) leveraging a hybrid CNN-Transformer architecture further refines performance. 3SGAN was trained and evaluated on a large dataset of 1408 Whole-Slide Images (WSIs) from two medical institutions, encompassing 101 distinct staining styles, with nucleus-level annotations required for only 5% of the data.
results3SGAN significantly outperformed state-of-the-art methods, achieving superior segmentation accuracy with an F1-score of 0.8140, mean IoU of 0.8201, and AJI of 0.6915. Simultaneously, it demonstrated substantial improvements in stain normalization quality, yielding a low RMSE of 0.0908, high PSNR of 21.0615, and SSIM of 0.8556 on the internal test set. External validation on independent MoNuSeg and PanNuke datasets, as well as on previously untested tumor-rich non-ROI regions from our in-house WSIs, confirmed strong generalizability with excellent stain normalization and top-tier segmentation accuracy across diverse staining protocols, tissue types, and pathological patterns.
conclusionsThe proposed 3SGAN framework demonstrates that high-performance nucleus segmentation and stain normalization can be achieved with minimal annotation requirements, offering a practical and scalable solution for digital pathology applications across diverse clinical settings and staining protocols.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.